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In Brief
Ohkawa and Welch show that intranuclear actin-based motility of the baculovirus type species AcMNPV drives viruses into nuclear envelope protrusions. Egress from the nucleus then requires actin-dependent disruption of nuclear envelope integrity. Post-egress actin-based motility facilitates virus transit to the plasma membrane for budding.
RESULTS AND DISCUSSION
To define the essential role of nuclear actin in baculovirus progeny production, we visualized the association of individual viral nucleocapsids with F-actin during budded virus (BV) production using a recombinant virus that expresses the major viral capsid protein VP39 fused to three copies of the fluorescent protein Dronpa (Autographa californica M nucleopolyhedrovirus [AcMNPV]-3Dr; this virus grew with normal kinetics but to a 3-fold lower titer than wild-type; Figure S1A ). We then carried out live-cell imaging in cultured Trichoplusia ni High Five cells expressing the F-actin marker Lifeact fused with mCherry (Lifeact-mCherry). We observed that newly assembled nucleocapsids underwent actin-based motility within the nucleus, generating characteristic actin comet tails (Figures 1A and 1B; Video S1, segment 1). The first instance of nuclear actin-based motility could be visualized at 12 ± 2 (mean ± SD) hr post-infection (hpi) ( Figure 1A ). This was followed by a pronounced burst of more frequent motility beginning at 16 ± 3 hpi, during which many moving viruses appeared within a relatively short time interval ($75 min). The timing of motility initiation corresponded with the formation of viral replication centers or virogenic stroma, which were observed by expression of VP39 fused with mCherry (VP39-mCherry) as dim structures starting at 13 ± 2 hpi and then bright structures starting at 16 ± 3 hpi. Thus, AcMNPV undergoes intranuclear actin-based motility, and this occurs concomitantly with viral progeny production.
To examine the mechanism of intranuclear nucleocapsid motility and compare it with motility in the cytoplasm during viral ingress, we measured key motility parameters. The speed of intranuclear motility was 13 ± 3 mm/min (mean ± SD; Figure 1C) , similar to what we previously observed for cytoplasmic motility (14 ± 4 mm/min) [6] . We additionally assessed the involvement of the viral P78/83 protein, an essential minor capsid protein that is conserved in lepidopteran NPVs and acts as a nucleation-promoting factor that activates the host Arp2/3 complex to assemble branched F-actin from G-actin [8] . We used the AcMNPV-3Dr virus carrying a mutation in P78/83 (Ile 358 / Ala 358 [I358A]) [8] that compromises its ability to activate the Arp2/3 complex in vitro and impairs actin-based motility. The AcMNPV-3Dr-I358A mutant exhibited reduced motility speed in the nucleus (5 ± 1 mm/min; Figure 1C ), similar to what was previously observed in the cytoplasm (8 ± 3 mm/min) [6] . These results indicate that intranuclear actin-based motility depends on P78/83 and the Arp2/3 complex and suggest that viral motility contributes to the pool of dynamic nuclear F-actin observed previously [8] .
Given that AcMNPV nucleocapsids use actin polymerization for movement within the nucleus and that F-actin is required for BV progeny production [9, 10], we hypothesized that nuclear actin might also play a role in egress of newly replicated viral nucleocapsids from the nucleus to the cytoplasm. It had previously been proposed that egress from the nucleus involved the association of nucleocapsids with protrusions of the nuclear envelope that project outward into the cytoplasm, the separation of these protrusions into double-membraned vesicular structures containing the virus [12] , and then virus escape into the cytoplasm. However, the contribution of actin toward nuclear envelope protrusion formation and the mechanism of virus egress were unknown. Using transmission electron microscopy (TEM) to image Spodoptera frugiperda Sf9 and Trichoplusia ni High Five cells infected with AcMNPV-3mC [6] at 24 hpi, we confirmed that AcMNPV nucleocapsids were present in double-membrane protrusions of the nuclear envelope (NE) that extended out >0.2 mm from adjacent regions of the nuclear periphery (Figures 2A, 2E , and 2F; virus-containing double membrane structures also appear adjacent to the nucleus in individual TEM sections and may be continuous with the NE). To determine the importance of actin polymerization and depolymerization in protrusion formation, we infected cells with AcMNPV-3mC and then treated with drugs that prevent G-actin assembly (latrunculin A) or stabilize F-actin (jasplakinolide). In drug-treated cells, we did not observe full NE protrusions but instead observed small bumps in the NE that did not contain nucleocapsids and extended only $0.1 mm from adjacent regions of the nuclear periphery ( Figures 2C-2F ). We call these ''nubs'' to distinguish them from protrusions. Nubs could also be seen in cells with newly synthesized viral DNA that did not yet show nucleocapsid formation (data not shown). This suggests that there are two steps in virus-induced NE protrusion formation: actin-independent formation of NE nubs that precedes nucleocapsid assembly and actin-dependent extension of longer NE protrusions. Additionally, in drug-treated cells, we were unable to detect nucleocapsids in the cytoplasm by electron microscopy ( Figures 2C-2E ) or by immunofluorescence microscopy ( Figures S1B and S1C ). These results indicate that the dynamic cycle of actin assembly and disassembly is crucial for viral movement to the nuclear periphery, extension of NE protrusions, and subsequent egress from the nucleus. Our results are also consistent with the failure of drug-treated cells to produce BV progeny [9, 10] .
We also used TEM to image Sf9 and High Five cells infected with the AcMNPV-3mC-I358A mutant at 24 hpi, and we observed intermediate and cell-type-specific phenotypes. The AcMNPV-3mC-I358A virus formed nubs in Sf9 cells and protrusions in High Five cells ( Figures 2B, 2E , and 2F). This intermediate phenotype confirms a role for intranuclear actin-based motility in the formation of NE protrusions and is also consistent with the fact that the mutant virus can still egress from the nucleus and produce BV progeny with reduced efficiency [6] . Figure S1 and Video S1.
To further investigate the role of viral actin-based motility in egress from the nucleus, we imaged moving AcMNPV-3Dr viruses at the inner nuclear periphery in live cells, first using lamin B tagged with mCherry (mCh-lamin B2) to visualize the NE (Figure 3A ; Video S1, segment 2). We observed individual nucleocapsids moving within NE protrusions that resembled those seen by electron microscopy. In subsequent experiments using AcMNPV-3Dr and visualizing F-actin (using Lifeact-mCherry), we observed viruses moving in circular paths, apparently trapped within NE protrusions, with their associated actin tails forming donut-shaped rings at the nuclear periphery ( Figure 3B ; Video S1, segment 3). Unexpectedly, when we visualized mCherrylamin B2 and F-actin using Lifeact tagged with TagBFP (Lifeact-TagBFP), we observed localized dissolution of fluorescent lamin B signal accompanied by a transient burst of actin polymerization ( Figure 3C ; Video S2, segment 1, left panel). In cases when events stayed in the focal plane of imaging, nascent actin comet tails could be visualized during egress (Video S2, segment 1, right panel) as nucleocapsids entered the cytoplasm and moved freely, unobstructed by the NE. Disruption of NE protrusions was also observed using a different NE marker, the integral inner nuclear membrane protein SUN2 tagged with triplemCherry (SUN2-triple-mCherry) (Video S2, segment 2). These results suggest that AcMNPV egress involves actin-based movement within NE protrusions, which is coupled with localized NE disruption, and subsequent actin-based motility in the cytoplasm.
We next sought to further test the notion that viral egress involves a local disruption of the NE, as suggested by the dissolution of fluorescent lamin B and SUN2 signals as egress occurred. To measure NE integrity, we expressed GFP tagged with a nuclear localization sequence (NLS-GFP) and then quantified the nuclear:cytoplasmic fluorescence intensity ratio of NLS-GFP per unit area ( panel shows uninfected cells. Note there was an overall decrease in NLS-GFP signal in uninfected cells due to photobleaching from long-term confocal imaging.). The leaking of NLS-GFP into the cytoplasm was dependent upon actin polymerization, as addition of latrunculin A or jasplakinolide or infecting with AcMNPV-3mC-I358A resulted in a slower rate of decrease of the nuclear:cytoplasmic NLS-GFP that was similar to the rate in uninfected cells ( Figures 4D-4G ). These results suggest that AcMNPV egress from the nucleus disrupts NE integrity and that this disruption requires actin polymerization and depolymerization and actin-based motility. We also tested the alternative hypothesis that egress occurs by outward transit through the nuclear pore, as with ingress into the nucleus [6, 13] . To test the potential involvement of nuclear pores, at a time approaching the late stage of infection (prior to the burst phase of actin-based motility), we microinjected cells with fluorescently labeled wheat germ agglutinin (WGA), which blocks trafficking through nuclear pores [14] and inhibits AcMNPV ingress into the nucleus [6] . WGA did not prevent egress from the nucleus, as virions were able to escape into the cytoplasm and undergo actin-based motility following WGA injection ( Figure S2A ; Video S4, segment 1, WGA in left panel and EGFP-actin in right panel). Furthermore, viral egress and subsequent actin-based motility in the cytoplasm were not prevented by treating cells approaching the late stage of infection with a drug that blocks the CRM1 nuclear export pathway, leptomycin B (Video S4, segment 2). Thus, AcMNPV does not egress from the nucleus by transit through the nuclear pore complex or by using a CRM1-mediated nuclear export pathway. Together with the abovementioned NLS-GFP studies, these results suggest that viral egress from the nucleus instead involves NE disruption and viral release into the cytoplasm.
Following egress from the nucleus, the mechanism by which AcMNPV nucleocapsids move to the plasma membrane and the involvement of actin and/or microtubules remained unclear. In particular, previous studies yielded conflicting results regarding the role of microtubules, with some finding that microtubule disassembly by drug treatment and silencing of kinesin light chain by RNAi inhibited BV production [15] [16] [17] and others finding that microtubule disassembly had no effect on BV release [18] . To resolve this controversy, we reassessed the effect of two drugs that have been used to disrupt microtubules, colchicine and nocodazole, on microtubule organization and BV production. We confirmed that colchicine is effective at depolymerizing microtubules in High Five cells, whereas nocodazole is not ( Figure S2B ) [18, 19] . However, despite its efficacy at disrupting microtubules, colchicine had no effect on BV release (Figure S2C) . Thus, microtubules are not important for BV production. Instead, as mentioned above, we observed nucleocapsids moving by actin-based motility following egress from the nucleus, starting at 13 ± 3 hpi (Figures 1A and S3 ; Video S5). The speed of motility in the cytoplasm was 10 ± 3 mm/min for AcMNPV-3Dr and 5 ± 1 mm/min for the AcMNPV-3Dr-I358A mutant ( Figure 1C ), similar to the speeds seen during ingress [6] . Furthermore, based on the effect of actin-disrupting drugs, actin is known to be crucial for BV production [9, 10] . These results suggest that, rather than using microtubules, AcMNPV uses actin-based motility for movement to the plasma membrane, where viruses acquire an envelope to form BV progeny.
Our study indicates that AcMNPV is a prolific manipulator of actin, having evolved to harness actin-based motility to facilitate several stages of infection, including ingress of input virus to the nucleus [6] as well as egress of progeny virus from the nucleus and movement of progeny to the plasma membrane for BV budding. Other viruses also induce NE breakdown to enable egress [1] . The mechanism employed by AcMNPV, however, which involves nuclear F-actin-dependent NE protrusion formation and disruption, has not been previously described. It may nevertheless represent a generalizable strategy for NE disruption during infection. Actin-mediated NE disruption by AcMNPV may involve rupture of inner and outer NE membranes. Alternatively, it may involve fusion of inner and outer NE membranes, which could be mediated by N-ethylmaleimide sensitive factor (NSF) or soluble NSF attachment receptor (SNARE) proteins, which are involved in AcMNPV nuclear egress [20] . Our data also point to a nucleocapsid-and actin-independent process that forms NE nubs prior to nucleocapsid-and actin-dependent protrusion formation. It was recently reported that a group of AcMNPV proteins interacts with components of the ESCRT-III complex and that ESCRT-III is required for nuclear egress [21] , suggesting these proteins may be involved in nub formation. Interestingly, F-actin within the nucleus of uninfected cells is reported to play a role in nuclear assembly and shape [22] , as well as intranuclear organization [23] , particularly in large oocyte nuclei. Moreover, linkages between the outer NE and the cytoplasmic actin network have been shown to promote both NE rupture in cells with defects in nuclear lamina organization [24] and NE stabilization in cells undergoing confined migration [25] . Pathogens often evolve to activate and exaggerate existing cellular pathways rather than inventing new pathways of their own. Therefore, studying how AcMNPV mobilizes actin for nuclear egress may reveal new cytoskeletal functions important for NE integrity, stability, and remodeling.
STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines Sf9 cells (ovarian cells from female Spodoptera frugiperda) were maintained in Grace's insect media (Gemini Bio-Products) with 10% fetal bovine serum (FBS; Gemini Bio-Products) or in ESF 921 media (Expression Systems) at 28 C, either in suspension or adherent culture. High Five and TN368 cells (ovarian cells from female Trichoplusia ni) were maintained in TNM-FH insect media (Gemini Bio-Products) with 10% FBS at 28 C in adherent culture.
Viruses
The virus used in this study was AcMNPV WOBpos, which can be propagated as a bacmid in E. coli [8] . The generation of AcMNPV-3mC (a virus with its vp39 gene fusion to three copies of the gene encoding mCherry) and AcMNPV-3mC-I358A (a virus with a mutation in p78/83 that results in the substitution of isoleucine 358 to alanine) were previously described [6] . To generate all other viruses, transfer plasmid vectors generated as described below were linearized, gel-purified, and co-electroporated with WOBpos (at least 30 fmol of linearized transfer vector with 0.2 mg of bacmid DNA) into BW25113/pKD46 E. coli, to introduce alterations by homologous recombination, as described previously [8] . These viruses include: AcMNPV-3Dr, a virus with an extra copy of the vp39 gene fused to three copies of the gene encoding Dronpa [29] ; AcMNPV-3Dr-I358A, a virus with an extra copy of the vp39 gene fused to three copies of the gene encoding Dronpa as well as the I358A mutation in the p78/83 gene; AcMNPV1mC, a virus with a vp39 gene fusion to one copy of the gene encoding mCherry under the control of the viral p10 promoter; and AcMNPV-3mCq, a virus with a vp39 gene fusion to three copies of the gene encoding mCherry that also contains two conservative nucleotide substitutions within the vp39 gene to eliminate the start site for transcription of the overlapping delayed early cg30 gene and hence has reduced early mCherry expression.
METHOD DETAILS Cloning of Viral Transfer and Expression Plasmids
The generation of a pACT plasmid that expresses EGFP-actin (pACT-GFP-actin; for insect cell expression) was previously described [30] . The transfer vector for generating AcMNPV-1mC was constructed by subcloning a fusion of the vp39 and mCherry genes into the p10 WOBCAT transfer vector (containing the AcMNPV p10 promoter (118911-118681 in the AcMNPV E2 genome; accession number GenBank: KM667940.1) in transfer vector pWOBCAT [6] ). The transfer vector for generating AcMNPV-3mCq was constructed by introducing two conservative nucleotide substitutions (TA to CC; at positions 75907-75908 in the AcMNPV E2 genome) into transfer vector 3mC [6] that altered the start site for transcription of the delayed early cg30 gene without altering the VP39 protein sequence. To generate the vp39 gene fusion to three copies of the Dronpa gene, three separate copies of Dronpa were PCR amplified from pKW2416 (a kind gift from K. Weis, ETH Zurich), and the three copies (with XbaI/EcoRI, EcoRI/XhoI, and XhoI/ApaI ends) were cloned in tandem into pBSKS+ (Agilent). The three tandem copies were then fused to vp39 with the same two mutations as in the 3mCq transfer vector, to generate 3Dr. 3Dr was moved into transfer vector pWOBGent6 [6] using BsiWI and ApaI to provide flanking regions of homologous sequences for recombination with the viral genome of WOBpos (generating AcMNPV-3Dr) and I358A (generating AcMNPV-3Dr-I358A), as described above. The plasmid that expresses Lifeact [31] fused with mCherry (Lifeact-mCherry) was generated by PCR-amplifying the mCherry gene (as described in reference [6] , but with XbaI and EcoRI sites), subcloning into the plasmid pEGFP-N1 (Clontech) containing the Lifeact gene [32] , and then transferring Lifeact-mCherry (with SpeI and BglII ends) into pACT [27] . The plasmid that expresses Lifeact tagged with three tandem copies of TagBFP [33] (Lifeact-TagBFP) was constructed by subcloning two (AvaI/blunt and blunt/BamHI cut) copies of TagBFP from pTagBFP-N (Evrogen) into Lifeact GFP vector [32] . A third copy of TagBFP (blunt/NotI) was then inserted into blunt/NotI cut plasmid, and this gene encoding Lifeact with three copies of TagBFP (blunt/NotI) was transferred into pACT (SmaI/NotI cut) for expression in insect cells (pACT-Lifeact-TagBFP). The plasmid expressing mCherry-Lamin B2 (human lamin B2) was constructed by cutting the corresponding gene from plasmid mCherry-C2 LB2 (a kind gift from R. Heald) and inserting the blunt/XbaI fragment into SmaI/XbaI cut pACT (to generate pACT-mCherry-lamin B2). The plasmid expressing NLS-GFP was constructed by cutting the gene encoding NLS-GFP from NLS-GFP-actin/pACT [27] and inserting the blunt/BamHI fragment into blunt/BamHI cut pACT (to generate pACT-NLS-GFP). The plasmid expressing SUN2 fused to three copies of the mCherry gene (SUN2-3xmC) was constructed by PCR amplifying SUN2 from SUN2-GFP/pcDNA4 [28] (a kind gift from K. Roux), cloning it into p10-3mC (same as 3mC described above, but with a baculovirus very late p10 promoter driving vp39-triple mCherry), and then moving SUN2-triple-mCherry into pACT by inserting a blunt-SalI fragment into pACT (blunt/XhoI cut).
Immunofluorescence and Live Cell Imaging
To visualize microtubules in High Five cells, 7.5x10 4 cells were plated to 22 mm 2 coverslips and allowed to settle for 1 h, after which fresh media containing either colchicine (10 mM) or nocodazole (80 mM) was added. After 4 h, coverslips were fixed with 4% formaldehyde in PHEM (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl 2 , pH 6.9) for 10 min, rinsed in PHEM, and then fixed in methanol for 3 min at À20 C. Following rinsing, coverslips were treated with E7 anti-tubulin antibody (Developmental Studies Hybridoma Bank, University of Iowa) and subsequently a goat anti-mouse secondary antibody linked to FITC (Zymed). In experiments to detect nucleocapsids in the cytoplasm, 2.25x10 5 High Five cells were plated to coverslips and settled overnight, followed by inoculation with AcMNPV-3Dr at a multiplicity of infection (MOI) of $30. At 12 hpi, media containing cytochalasin D (EMD Bioscience; 1 mg/ml), jasplakinolide (Calbiochem; 1 mM) or latrunculin A (Biomol; 4 mM) was added. Coverslips were pre-extracted at 18 hpi in 0.1% Triton X-100/cytoskeleton buffer (10 mM MES pH 6.1, 138 mM KCl, 3 mM MgCl 2 , 2 mM EGTA) containing 0.32 M sucrose, and 1 mg/ml phalloidin [6] , fixed in 4% formaldehyde in PHEM, then actin was stained with phalloidin Alexafluor-568 (Invitrogen) and DNA with DAPI (Invitrogen). Cells were selected for analysis based on the presence of virogenic stroma (detected by the presence of bright DAPI nuclear foci as well as nuclear capsid signal), signifying late stage viral infection.
For time-lapse imaging to visualize AcMNPV-induced nuclear and cytoplasmic actin comet tails, High Five cells were plated to 35 mm coverslip dishes (MatTek) at 2.4x10 5 to 4.0x10 5 cells per dish, in 2 mL of media, and infected with AcMNPV-3Dr or AcMNPV-3Dr-I358A at an MOI of $10, with images captured at 5 s intervals between 9 and 20 hpi. Cells were selected for time-lapse imaging based on the presence of actin comet tails in the nucleus or cytoplasm. For visualization of actin comet tails within protrusions of the nuclear membrane and in the cytoplasm, AcMNPV-3Dr virus was used at an MOI of $50. For NLS-GFP experiments, AcMNPV-3mCq virus was used at an MOI of $40, and images were captured at 15 min intervals. Cells were selected for time-lapse imaging based on an initial high contrast ratio of nuclear to cytoplasmic GFP signal, as well as virus-expressed VP39-mCherry (present at a very low level at the start of imaging). Transient transfections into cells were performed using the TransIT-2020 or TransIT-Insect reagents (Mirus Biologicals) according to the manufacturer's protocol. In all experiments, cells were transfected 1 d post-plating with plasmids expressing fluorescent protein fusions (the amount of DNA transfected into cells was 0.05-0.2 mg for pACT-Lifeact-mCherry, 1 mg pACT-mCherry-Lamin B2, 20 mg pACT-Lifeact-TagBFP, 0.04 mg pACT-NLS-GFP, 5 mg pACT-GFP-actin). Images of virus-induced actin structures were captured at 5 s intervals with the exception of nuclear envelope rupture videos, for which images were captured at 10 s intervals. For NLS-GFP experiments, high five cells were transfected with pACT-NLS-GFP two days in advance of imaging, which commenced at $9 hpi.
Microscopy was performed using a Nikon Ti Eclipse confocal microscope with a Yokogawa CSU-XI spinning disc, 100X (1.4 NA) Plan Apo objective, a Clara Interline CCD camera (Andor Technology), and MetaMorph software (Molecular Devices). Images were processed using ImageJ software [34] .
Blockage of Nuclear Pores and CRM1/Exportin 1 Export
To observe whether nuclear pore blockage hinders virus escape from the nucleus, cells were microinjected with wheat germ agglutinin (WGA). High Five cells knocked from four confluent 25 cm 2 T-flasks (transfected with 7 mg of GFP-actin/pACT plasmid)
were settled to coverslip dishes by sequentially plating 5.4x10 6 cells (after 2 min cells are removed and fresh cells are plated, repeated for a total of 4 plating steps; healthy cells adhere rapidly while unhealthy cells take longer to adhere). Dishes were inoculated with 600 ml of pre-warmed WOBpos ($2x10 7 PFU). At 16 hpi, cells were microinjected with WGA-TRITC (0.5 mg/ml), using Femtotips with a FemtoJet microinjector controlled with an InjectMan micromanipulator (all from Eppendorf), using a pressure of 80 hPa, a time of 0.4 s, and a compensation pressure of 30 hPa [6] . Cells were visualized on a spinning disc confocal microscope at 28 C from $18 hpi. Unhindered viral escape from the nucleus was assessed by the appearance of actin comet tails in the cytoplasm after microinjected cells showed WGA signal at the nuclear periphery.
To test if AcMNPV uses the CRM1/exportin 1 export pathway to escape the nucleus, 3.6x10 5 High Five cells were settled in 2 mL of media to 35 mm coverslip dishes (MatTek) overnight, then transfected with 5 mg of pACT-GFP-actin. One day post-transfection, cells were infected with AcMNPV-3mC virus at an MOI of $50. At 14 hpi, cells with nuclear mCherry-VP39 signal were identified, media containing leptomycin B (to a final concentration of 25 ng/ml) was added, and cells were imaged at 10 min intervals overnight, as described above for WGA.
Electron Microscopy
For transmission electron microscopy, 2.5x10 6 Sf9, 2.5x10 6 TN368, or 1.3x10 6 High Five cells were plated to 6 cm dishes and inoculated with AcMNPV-3mC or AcMNPV-3mC-I358A virus at an MOI of 10. At 20 hpi, cells were washed with 100 mM sodium cacodylate (pH 7.2) with 2% sucrose, fixed in 2% glutaraldehyde, 100 mM cacodylate, and 2% sucrose for 5 min, scraped from the plastic substrate, and further fixed overnight in fresh fixative plus 0.3% BSA. Cells were then washed with 0.1 M sodium cacodylate (pH 7.2) and post-fixed in 1% osmium tetroxide, 0.8% potassium ferricyanide 1 h, washed in 0.1 M sodium cacodylate, then water, and stained in 1% uranyl acetate in 50 mM sodium maleate pH 5.2 for 1 h. Samples were washed with water and dehydrated in increasing concentrations of acetone before being infiltrated with resin for sectioning. Once on grids, sections were stained with 2% uranyl acetate in 70% methanol, rinsed in decreasing concentrations of methanol, and stained with Reynolds lead citrate. Images were captured using a Tecnai 12 (120 KV) transmission electron microscope.
Viral Growth Curves
To assess viral growth, 4.4x10 6 Sf9 cells were plated to 6 cm dishes and infected with WOBpos or AcMNPV-3Dr at an MOI of 10. After a 1 h adsorption period, cells were rinsed three times with fresh media, and then media was added containing 10 mM colchicine or 80 mM nocodazole or no drug. Growth curves were performed by taking aliquots at specified times which and freezing them at À80 C until titration was performed by plaque assay. For plaque enumeration, 6.8x10 4 Sf9 cells were plated onto 5 mm diameter wells (on 12 well slides), inoculated with 10 ml of virus dilution (4 wells/dilultion) for 1 h, then following removal of the inoculum, overlaid with $40 ml of 0.6% methylcellulose in Grace's media with 10% FBS [6] . After 3 d, assays were processed by fixation with 45% acetone and 25% formalin in phosphate buffer (5 mM Na 2 HPO 4 , 24 mM KH 2 PO 4 ) and stained with a primary mouse antibody against the viral glycoprotein GP64, then a goat anti-mouse secondary antibody linked to HRP. TrueBlue peroxidase substrate (KPL) was then added and after mounting coverslips on slides, plaques were identified and quantified as patches of blue-staining cells.
QUANTIFICATION AND STATISTICAL ANALYSIS

Statistical Analyses
Statistical details (statistical test used, number of samples, and p values) for each experiment can be found in the Figure labels or legends. Statistical analyses of average times of virus-induced events, nucleocapsid speeds, NE protrusion heights, average GFP intensity density ratios, linear regressions, and viral growth curves were conducted using Prism (Graph Pad Software). Statistical significance was determined by one-way ANOVA analysis with Tukey's post tests for multiple comparisons. Asterisks indicate the corresponding statistical significance: **p < 0.01, ***p < 0.001, and n.s. = non-significant. For analysis of the slopes of the linear regressions of average GFP intensity density ratios, SPSS Statistics (IBM) was used. Based on a linear mixed model analysis, the rate of decrease of the fluorescence intensity signal per unit area of the uninfected, AcMNPV-3mC-I358A virus infection, jasplakinolide, and latrunculin A treatments were significantly different from the AcMNPV-3mC treatment (p < 0.001).
